Adenocarcinoma

---

Summary

Adenocarcinoma is the most common type of colorectal cancer, which is cancer that starts in the colon or rectum. This cancer originates from glandular cells that line the inside of the colon and rectum. It falls under the histological classifications of tubular, villous, and tubulovillous adenomas, with each type varying based on the structure and growth patterns of the cancerous cells.

Symptoms

Colorectal adenocarcinoma often presents with the following symptoms:

• Changes in bowel habits (diarrhea or constipation)
• Blood in stool or rectal bleeding
• Abdominal discomfort or bloating
• Unexplained weight loss
• Fatigue or weakness
• A feeling that the bowel does not empty completely

It is important to note that early-stage colorectal cancer may not cause any symptoms, which is why regular screening is crucial.

Standard Treatments

1. Surgery: The primary treatment for localized colorectal adenocarcinoma is surgical resection. This can involve:

   • Colectomy: Removal of part or all of the colon.
   • Proctectomy: Removal of part or all of the rectum.
   • These surgeries are often accompanied by lymph node removal to check for cancer spread.

2. Chemotherapy: Used to kill cancer cells and reduce the risk of recurrence. Common drugs include 5-fluorouracil (5-FU), capecitabine, oxaliplatin, and irinotecan.

3. Radiation Therapy: Often used in rectal cancer to shrink tumors before surgery or to kill remaining cancer cells after surgery.

4. Targeted Therapy: Utilizes drugs that specifically target cancer cell growth mechanisms, such as:

   • Bevacizumab: An angiogenesis inhibitor.
   • Cetuximab and Panitumumab: EGFR inhibitors.

5. Immunotherapy: In cases where the cancer exhibits specific genetic markers (e.g., MSI-H or dMMR), immunotherapy drugs like pembrolizumab and nivolumab may be effective.

Experimental Treatments

Research is ongoing to develop new treatments for colorectal adenocarcinoma. Some experimental approaches include:

• CAR T-cell Therapy: Modifying a patient’s T-cells to better recognize and attack cancer cells.
• Cancer Vaccines: Developing vaccines to stimulate the immune system against colorectal cancer cells.
• Gene Therapy: Techniques aimed at correcting genetic mutations responsible for cancer development.

Side Effects of Treatments

• Surgery: Risks include infection, bleeding, and changes in bowel habits.
• Chemotherapy: Side effects can range from nausea, vomiting, and hair loss to neuropathy and increased infection risk.
• Radiation Therapy: May cause skin irritation, fatigue, and bowel discomfort.
• Targeted Therapy: Potential side effects include skin rashes, diarrhea, and hypertension.
• Immunotherapy: Can lead to immune-related side effects such as inflammation of healthy organs, skin reactions, and fatigue.

Modernity of Treatments

• Surgical Techniques: Continually evolving, with laparoscopic and robotic-assisted surgeries offering less invasive options and quicker recovery times.
• Chemotherapy: The use of combination chemotherapies has been standard since the late 1990s and early 2000s, with ongoing refinements.
• Targeted Therapies: These have become more prevalent since the mid-2000s, with ongoing development of new agents.
• Immunotherapy: Gaining traction in the 2010s, with significant advancements in personalized medicine and biomarker identification.

Overall, the field of colorectal cancer treatment is dynamic, with ongoing research into more effective and less toxic therapies. Regular screening and advancements in genetic and molecular profiling continue to improve patient outcomes.